News & Training
Staburo news about trainings, events and more
New publication in BMC Bioinformatics: shadowVIMP: permutation-based multiple testing-controlled variable selection
New publication in BMC Bioinformatics: shadowVIMP: permutation-based multiple testing-controlled variable selection We’re pleased to share that our methodological work on variable selection with random forests has now been published in BMC Bioinformatics. The paper...
Staburo Top Company 2026
Staburo Top Company 2026 We’re happy to share that Staburo has once again been awarded as Kununu Top Company 2026, and we’ve now received this recognition three years in a row (2024, 2025, 2026). What makes this award special: it’s based on independent reviews from...
Biomarkers at Staburo
Biomarkers at Staburo In 2024 at Staburo was about building momentum in the area Biomarkers. Deepening our engagement in the PSI Biomarker SIG, strengthening collaborations, and developing the ideas that would later become deliverables. In 2025, we developed and...
Staburo Workshop Week meets Christmas Party
After an inspiring and insightful week of feedback workshops conducted by BerlinAlley, we wrapped things up in the most festive way possible: our annual Christmas party! We kicked off the evening in the company canteen, where the smell of homemade Glühwein and Punsch...
Staburo @ PSI/EFSPI Vaccines Statistics Workshop
Staburo @ PSI/EFSPI Vaccines Statistics Workshop On October 23, 2025, Staburo, represented by Tim Müller, attended the PSI/EFSPI Vaccines Statistics Workshop at the GSK site in Wavre. The workshop brought together a focused group of highly knowledgeable statisticians...
Staburo contributes to bioinformatic analysis in a Phase 2 chronic kidney disease (CKD) study
Staburo contributes to bioinformatic analysis in a Phase 2 chronic kidney disease (CKD) study We are pleased that part of our work got published as a scientific article in the International Journal of Molecular Sciences on November 7th, 2025. In this publication, we...
Staburo contributes to bioinformatic analysis in psoriasis phase 2 study
Staburo contributes to bioinformatic analysis in psoriasis phase 2 study We are pleased that part of our work has been published as a letter to the author in the Journal of investigative dermatology. In this publication we supported the bioinformatic analysis in a...
Meet the Management – Lauri Õnnik– Director Data Management
Meet the Management – Lauri Õnnik– Director Data Management As Staburo continues to grow, so does our management team and with growth come new responsibilities and opportunities! We are excited to announce that Lauri Õnnik has been promoted to Director Data...
Staburo at Wiesn 2025
Staburo at Wiesn 2025 On 25 September 2025, the Staburo GmbH team came together to enjoy a fun evening at the Oktoberfest in Munich. This yearly tradition was a wonderful opportunity to connect beyond the usual work environment, as employees, including many of our...










